Viravarn Luvira
ORCID: 0000-0001-9270-3720Also affiliated with Mahidol Oxford Tropical Medicine Research Unit
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial”.
Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +42 more
Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +41 more
William HK Schilling, Podjanee Jittamala, Simon Boyd, Viravarn Luvira, Tanaya Siripoon +21 more
Sirikamon Koosakunirand, Taniya Kaewarpai, Watcharapong Piyaphanee, Pornsawan Leaungwutiwong, Viravarn Luvira +2 more